Skip to main content

Research Repository

Advanced Search

The pathophysiology of increased hepatic IGF1 expression in an ovine model of polycystic ovary syndrome

Siemienowicz, Katarzyna; Boswell, Lyndsey; Carr, David; Mina, Theresia; Connolly, Fiona; Rae, Mick; Duncan, Colin

Authors

Lyndsey Boswell

David Carr

Theresia Mina

Fiona Connolly

Colin Duncan



Abstract

Exposure of pregnant sheep to increased concentrations of testosterone during midgestation results in a PCOS-like condition in the female offspring that includes increased hepatic IGF1. The aim of this study was to investigate the molecular pathophysiology of this increase. We studied 11-month-old female offspring whose mother had been treated with testosterone propionate (TP: 100 mg) in oil (n=8), or oil control (n=4) twice weekly from day 62 to 102 gestation. The first experiment was to determine if altered IGF1 was a consequence of prenatally programmed differential gene methylation. We assessed IGF1 CpG methylation using pyrosequencing. There was no IGF1 gene hypomethylation (P>0.05) associated with prenatal TP exposure. The next experiment was to assess if the prenatally programmed primary hyperinsulinaemia, resulted in augmented IGF1 through altered GH secretion or action. There was no difference in pituitary GH1 expression (P>0.05), number of somatotrophs assessed by immunohistochemistry (P>0.05) or serum GH concentrations (P>0.05). In addition there were no differences in hepatic GHR (P>0.05) or expression of other GH-regulated genes including HNF6/ONECUT1, G6PC and SLC2A2 (P>0.05). The next experiment was to determine if contemporaneous androgen exposure was involved. The sheep express higher hepatic AR as well as having increased capacity for ovarian and adrenal androgen synthesis. We investigated the effects of two weeks of TP (100 mg twice weekly) (n=5) or control (n=5) on normal female sheep. This regimen did not alter hepatic IGF1 expression (P>0.05). To date the pathophysiology of increased hepatic IGF1 in the ovine model of PCOS is unclear. As circulating insulin and hepatic NR3C1 (P

Citation

Siemienowicz, K., Boswell, L., Carr, D., Mina, T., Connolly, F., Rae, M., & Duncan, C. (2014, May). The pathophysiology of increased hepatic IGF1 expression in an ovine model of polycystic ovary syndrome. Poster presented at 16th European Congress of Endocrinology, Wroclaw, Poland

Presentation Conference Type Poster
Conference Name 16th European Congress of Endocrinology
Start Date May 3, 2014
End Date May 7, 2014
Online Publication Date Apr 17, 2014
Deposit Date Aug 21, 2019
Journal Endocrine Abstracts
Print ISSN 1479-6848
DOI https://doi.org/10.1530/endoabs.35.p683
Public URL http://researchrepository.napier.ac.uk/Output/1149535
Additional Information DOI (https://doi.org/10.1530/endoabs.35.P683) leads to published book of abstracts, which includes a published version of the poster: https://www.endocrine-abstracts.org/ea/0035/eposters/ea0035p683_eposter.pdf